Crossref
Designing of Novel 6(H)-1,3,4-Thiadiazine Derivatives as MMP12 Inhibitors: A MLR and Docking Approach
American Journal of Pharmacological Sciences · 2013
DOI: 10.12691/ajps-1-2-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmacological Sciences, 2013. Verfasst von Ajeet und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ajeet, Tripathi, L., & Kumar, P. (2013). Designing of Novel 6(H)-1,3,4-Thiadiazine Derivatives as MMP12 Inhibitors: A MLR and Docking Approach. American Journal of Pharmacological Sciences. https://doi.org/10.12691/ajps-1-2-3
Vancouver
Ajeet, Tripathi L, Kumar P. Designing of Novel 6(H)-1,3,4-Thiadiazine Derivatives as MMP12 Inhibitors: A MLR and Docking Approach. American Journal of Pharmacological Sciences. 2013. doi:10.12691/ajps-1-2-3
BibTeX
@article{Ajeet2013,
author = {Ajeet and Tripathi, Laxmi and Kumar, Praveen},
title = {Designing of Novel 6(H)-1,3,4-Thiadiazine Derivatives as MMP12 Inhibitors: A MLR and Docking Approach},
journal = {American Journal of Pharmacological Sciences},
year = {2013},
doi = {10.12691/ajps-1-2-3}
}
EUVIMED